Physician profile
Eric Wang
NPI 1821483371
$1,405.20
in general payments reported to CMS, 2019-2025
10 companies · $225 in 2025
The $225 reported for 2025 was more than what 83% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $165 · 2021: $38.21 · 2022: $378 · 2023: $397 · 2024: $202 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550 · Travel and Lodging: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.67 |
| Travel and Lodging | $274.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $450.11 | 2022-2024 | Sprint Pns System |
| Stryker Corporation | $274.00 | 2023 | Scopis Ent |
| Nevro Corp. | $228.47 | 2020-2022 | |
| Appliedvr INC | $224.82 | 2025 | Relievrx |
| Takeda Pharmaceuticals U.S.A., INC. | $90.54 | 2021-2023 | Entyvio |
| Grt US Holding, INC. | $60.00 | 2022 | |
| Janssen Biotech, INC. | $21.18 | 2023 | Stelara |
| Averitas Pharma INC. | $20.94 | 2024 | Qutenza |
| Ethicon US, LLC | $20.39 | 2021 | |
| Axonics, INC. | $14.75 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.